CSPC Pharmaceutical Group Limited

HK$8.45As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1093Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 9.94%
Div yield 4.26%
ROE 20.90%
Drug Manufacturers (General)
Beta (5Y) 0.77
PE TTM 11.25
TSR TTM 15.27%
Mkt cap HK$96.47B
ROIC 31.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.26
(2.30%)
159.10%
Hold 5|12|1|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.14
2.79%
0.46%
1.01%
9.08%
Revenue¥B
5.676
5.835
5.660
5.549
(5.44%)
(4.17%)
(4.72%)
(4.90%)
Peers (US$12.30B)
Cap (US$)
PE
3.738B
6.110x
Capital
TTM
5Y
10Y
Leveragex
1.964
(0.191)
(0.172)
EBIT/Intx
0.668
1.941
2.072
Own earn%
88.76
(23.40)
(30.47)
Sh yield%
49.13
39.17
34.91
Owners
Insiders/Inst%
7.91
46.68
Short interest%
1.96
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–4
$1 testx
0.0
Incr. ROIC%
−2